Investor · 1 deal
New York, OS
Every published round Aria Growth Partners took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Ultra Violette | Series B | 25 Jan 2024 | $15m | Lead | SmartCompany (26 Apr 2024), SmartCompany (10 Apr 2024), Forbes Australia (8 Apr 2024), SmartCompany (25 Jan 2024), SmartCompany (25 Jan 2024), Forbes Australia (24 Jan 2024), Women's Agenda |
Companies Aria Growth Partners has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Ultra Violette | 25 Jan 2024, Series B | 1 | 1 |
Fund closes reported for Aria Growth Partners, as distinct from the investments it has made.
Companies Aria Growth Partners has backed that another company then bought. An exit for the holding, not a deal Aria Growth Partners did.
Stories naming Aria Growth Partners. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of January raises: Sonder took $16 million in a Series B extension, Ultra Violette landed $15 million from Aria Growth Partners, VAPAR added $5 million; Sonder also named a new chairman.
Melbourne sunscreen brand Ultra Violette has taken its first outside capital, $15 million from US investor Aria Growth Partners, to enter North America; the piece also recalls Aesop and Bondi Sands exits.
Also Forbes Australia·SmartCompany·SmartCompany·SmartCompany·SmartCompany·Forbes Australia